“⌛팔로우주소 【위너보증.com / 가입코드 9122】 stake가입 ⌛”的搜索结果，显示 321-330 项，共有 13238 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purposes of this study are to analyze the ovarian function of female premenopausal melanoma survivors who have undergone immunotherapy, and compare with ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The overall goal of this project is to study a new 3D ultrasound imaging technology for evaluation of axillary lymph nodes in patients with breast cancer. A ...

3. 地中海贫血- 症状与病因- 妙佑医疗国际

   该遗传性疾病的一些类型往往在2 岁之前显现，往往会引起贫血。更严重的疾病类型需要定期输血。

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... follow-up therapy. Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of ...

5. 皮肤科- 临床试验- 妙佑医疗国际

   The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...

6. 广告和赞助- 妙佑医疗国际

   美国食品和药品管理局批准的处方药; 与健康有关的消费品; 健身产品或服务; 医疗产品或器械; 药房（零售和在线药房，VIPPS 计划仅适用于在线药房 ...

7. 乳腺癌精准医疗 - 医生与科室 - 妙佑医疗国际

   了解基因检测如何帮助定制您的癌症治疗计划。精准医疗正在不断改善乳腺癌诊断、治疗和预防。

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... follow-up to identify those who developed breast cancer (cases) and those who did not (controls); the application of potential biomarkers of risk to this ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... follow-up therapy. Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... follow-up therapy. Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of ...